Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
The program of renoprotection in patients with diabetes mellitus (DM) is based on a conceptual model of development and progressionof diabetic kidney disease, which is the result of combined impact of genetically modulated metabolic and hemodynamic factors. Compensationof carbohydrate metabolism, wh...
Guardado en:
Autores principales: | Minara Shamkhalovna Shamkhalova, Marina Vladimirovna Shestakova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0b7dc2b00c94888a3ecc8ecad6405f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
All-Russia congress ?Diabetes and kidneys?, 17-19 may 2009, Moscow
por: Minara Shamkhalovna Shamkhalova
Publicado: (2009) -
Diabetes mellitus and chronic kidney disease: achievements, unresolved problems, and prospects for therapy
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2011) -
Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2013) -
Prevalence of anemia in patients with type 1 and type 2 diabetes mellitus with chronic renal disease
por: Sergey A. Martynov, et al.
Publicado: (2017) -
New prospects in the treatment of diabetes mellitus
por: Minara Shamkhalovna Shamkhalova, et al.
Publicado: (2012)